The 340B rebate pilot was to have gone into effect on January 1. The American Hospital Association and other groups sued to ...

The First Circuit upheld a district court’s pause of the controversial pilot on Wednesday. It’s a setback for the Trump ...

Court blocks US gov's 340B Rebate Model Pilot Program, citing failure to meet admin law reqs. Hospital groups argued for ...

The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal ...

The federal 340B Drug Pricing Program, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to healthcare organizations that care for ...

Following Eli Lilly and Johnson & Johnson, Sanofi is aiming to change how it participates in the 340B program, a federal drug pricing program created in 1992, The Wall Street Journal reported Nov. 22.

The 340B Drug Discount Program was designed to help safety-net providers make drugs available to low-income patients and earn revenue. Drug manufacturers have put restrictions on which pharmacies ...

The U.S. Department of Health and Human Services is appealing Monday's ruling that affects how much hospitals pay for drugs ...

The 340B program is criticized for generating revenue rather than solely aiding underinsured patients, impacting community providers and Medicare patients. Pharmaceutical companies face challenges ...

As the Trump administration prepares to force its Most Favored Nation price controls on drug makers, a major U.S. lobbying group is pushing for a change to drug discounts law that would necessitate a ...

The use of targeted therapy was similar between patients living in areas with the highest 340B penetration and patients living in areas with the lowest 340B penetration. Participation in the 340B Drug ...